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Summary
Using methylation-sensitive restriction enzymes, we
characterized the methylation pattern on the 5′ side of
the CTG repeat in the DMPK gene of normal individuals
and of patients affected with myotonic dystrophy, show-
ing expansions of the repetitive sequence. The gene seg-
ment analyzed corresponds to the genomic SacI-HindIII
fragment carrying exons 11–15. There is constitutive
methylation in intron 12 at restriction sites of SacII and
HhaI, localized 1,159–1,232 bp upstream of the CTG
repeat, whereas most, if not all, of the other sites of
SacII, HhaI, and HpaII in this region are unmethylated,
in normal individuals and most of the patients. In a
number of young and severely affected patients, how-
ever, complete methylation of these restriction sites was
found in the mutated allele. In most of these patients,
the onset of the disease was congenital. Preliminary in
vivo footprinting data gave evidence for protein-DNA
contact in normal genes at an Sp1 consensus binding
site upstream of the CTG repeat and for a significant
reduction of this interaction in cells with a hypermethy-
lated DMPK gene.
Introduction
Myotonic dystrophy (DM; OMIM 160900 [http://
www3.ncbi.nih.gov:80/htbin-post/Omim/dispmim?
160900] is an autosomal dominant multisystemic dis-
order that includes weakness and wasting of distal limb
and face muscles and progressive myotonia (Harper
1989). The clinical manifestation is extremely variable.
The most severe form is congenital, and symptoms com-
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prise generalized muscular hypotonia, neonatal respi-
ratory distress, feeding difficulties, bilateral facial weak-
ness, talipes, delayed motor development, a high
neonatal mortality rate, and mental retardation (Harper
et al. 1992). The underlying mutations are expansions
of the CTG repeat in the 3′ UTR of the DM kinase
(DMPK) gene (GenBank X61378; http://www.ncbi
.nlm.nih.gov/Web/Genbank/) (Aslanidis et al. 1992;
Brook et al. 1992; Buxton et al. 1992; Harley et al.
1992). The repeat size shows some correlation with age
at onset and with the severity of the disease (Hunter et
al. 1992; Reardon et al. 1992; Tsilfidis et al. 1992), but
there is no simple causal relation.
Several triplet-repeat expansions localized within a
CpG island lead to hypermethylation of the correspond-
ing gene region (Oberle´ et al. 1991; Hirst et al. 1993;
Knight et al. 1993; Nancarrow et al. 1994; Parrish et
al. 1994; Jones et al. 1995; Schwemmle et al. 1997). In
fragile X syndrome (OMIM 309550 [http://
www3.ncbi.nih.gov:80/htbin-post/Omim/dispmim?
309500]), hypermethylation of the CpG island of the
FMR1 gene (GenBank X61378; http://www.ncbi
.nlm.nih.gov/Web/Genbank) is associated with loss of
transcription factor binding to the promoter region,
which results in transcriptional repression (Bell et al.
1991; Oberle´ et al. 1991; Pieretti et al. 1991; Verkerk
et al. 1991; Sutcliffe et al. 1992; Verheij et al. 1993;
Schwemmle et al. 1997). In this study, we analyzed part
of the CpG island at the 3′ end of the DMPK gene for
the methylation status as well as for a possible functional
role of this island in transcriptional regulation.
According to previous reports, there has been no ev-
idence of either parental imprinting playing a role in
differential allelic expression of the DMPK gene (Jansen
et al. 1993) or any allele-specific DNA methylation
(Shaw et al. 1993). However, in contrast to the latter
study, we discovered hypermethylation associated with
reduced protein interaction at an Sp1 binding site lo-
calized in a gene segment upstream of largely expanded
repeats with x1,000 CTG triplets. This modification of
disease alleles was found in young, severely affected pa-
tients and may be another genetic factor causally related
to earlier onset and more severe manifestation.
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Material and Methods
Cell Cultures
Cell cultures were established from dissected dura ma-
ter of a 16-wk-old DM fetus with a very large expansion
(P57F), from skeletal muscle material of another, 13-wk-
old, DM fetus (P70F), and from skin biopsies of normal
adults, as described elsewhere (Wo¨hrle et al. 1995;
Schwemmle et al. 1997). All cell cultures were main-
tained in Dulbecco’s Modified Eagle’s Medium
(DMEM).
Genomic DNA Isolation and Southern Blot Analysis
Genomic DNA was extracted from white blood cells
of various DM patients and normal individuals and from
cultured fibroblasts, by use of standard procedures. De-
tailed information on the patients and on the sources of
DNA samples are given in table 1. Aliquots were di-
gested with restriction endonucleases (BamHI, HpaII,
HhaI, HindIII, SacI, or SacII), separated on 0.8% aga-
rose gels, blotted onto Hybond N membranes, and hy-
bridized with DNA probe pM10M6 radiolabeled by the
random priming method. For analysis of DNA meth-
ylation, two types of experiments were carried out: (1)
digestion of the genomic SacI-HindIII fragment of the
DMPK gene with methylation-sensitive enzymes SacII or
HhaI on triple digests; and (2) digestion of the genomic
BamHI fragment with HpaII on double digests. Digests
were carried out at standard conditions. Expansion sizes
were measured on SacI  HindIII digests.
In Vivo Footprinting and Ligation-Mediated PCR
Analysis
For in vivo dimethyl sulfoxide (DMSO)–footprinting
analysis, the cultured cells were washed twice with phos-
phate-buffered saline (PBS) and were subsequently
treated with 0.1% DMSO in DMEM without serum for
8 min at room temperature. The DMSO-containing me-
dium was then quickly removed, and the cells were
washed with ice-cold PBS. DNA was then extracted by
standard procedures, treated with piperidine, and finally
subjected to ligation-mediated PCR (LMPCR), accord-
ing to the protocols of Mueller and Wold (1989) and
Pfeifer et al. (1989), which are described in detail in
Schwemmle et al. (1997). The primers used for LMPCR
of the lower strand were (1) 5′-GCC CCG TTG GAA
GAC TGA-3′, (2) 5′-CCA CCC ACC GCC TGC CAG
TTC ACA-3′, and (3) 5′-CGA GCG TGG GTC TCC
GCC CAG CTC CAG T-3′.
Results
Constitutive Methylation
A schematic illustration of the gene structure, includ-
ing restriction maps of the investigated gene region and
the distribution of CpG dinucleotides, is presented in
figure 1. On the SacI-HindIII fragment, which overlaps
with probe pM10M6 (Brook et al. 1992) and includes
the CTG repeat, are numerous restriction sites of the
methylation-sensitive enzymes HhaI and HpaII and two
sites of SacII, which is also sensitive to methylation. On
SacI  HindIII double digests (fig. 2a), probe pM10M6
hybridizes to a normal fragment of ∼1.78 kb. This is
enlarged in mutated genes according to expansion of the
CTG repeat carried on this fragment. Triple digests with
SacIHindIII SacII of DNA from normal individuals
resulted in SacI-SacII fragments of 1.55 kb, whereas the
expected 1.2-kb SacII-SacII fragments were missing. Be-
cause there is also absence of a 1.4-kb SacII-HindIII
fragment, this finding indicates constitutive methylation
of the upstream site of SacII. Cleavage at the distal SacII
site is also demonstrated by BamHI  SacII double di-
gests, resulting in a 1-kb fragment instead of the 1.4-kb
BamHI fragment carrying only the distal SacII site (not
shown). Triple digests, SacIHindIIIHhaI, gave 0.9-
kb fragments, which are expected to occur if restriction
sites of HhaI in intron 12 and exon 13 are also involved
in this constitutive methylation and if most, or all, HhaI
sites between exon 13 and the CTG repeat are un-
methylated. On BamHI  HpaII double digests, no re-
striction fragments were seen, which indicates that in
normal DMPK genes many, if not all, of the numerous
HpaII sites on the BamHI fragment are unmethylated.
In the DNA of all DM patients examined, an expan-
sion of the CTG repeat was detected on SacI  HindIII
digests, giving the normal band at x1.78-kb fragments
corresponding to the various expansions (fig. 2a and 2c).
After cleavage with SacI  HindIII  SacII, the normal
signals are still seen, whereas, in many patients, the ex-
pansions could no longer be detected clearly (exceptions
are described below, in the Hypermethylation of Disease
Alleles in Severely Affected Patients subsection). This
finding confirms that the restriction site of SacII, 42 bp
upstream of the repeat, is unmethylated. Cleavage of this
site results in a restriction fragment with the repeat
flanked by single-copy sequences of 42 bp on the 5′ and
126 bp on the 3′ side. The expanded repeats usually
could not be visualized in this situation, because these
expansions already appeared as broad smears when car-
ried on much larger genomic fragments. On SacI 
HindIII  HhaI digests, again, only the normal 0.9-kb
bands were detected, which shows that the repeat is not
carried on such a fragment and that sites of HhaI ad-
jacent to the unmethylated SacII site are also unmethy-
280 Am. J. Hum. Genet. 62:278–285, 1998
Table 1
DM Patients, by Methylation Status
Methylation
Status and
Patient
Age at Examination
(years)
Expansion Size
(kb)
Parental
Origin of
Mutation Disease Status
Hypermethylation:
P57F Prenatal 5.5 Maternal (CMD)
4211 !1 3.6 Maternal CMD
3842 !1 3.55 Maternal CMD
3692 !1 3.5 Maternal CMD
1496 ? 3.5 Maternal CMD
4106 24 3.4 Maternal CMD
3320 12 3.4 Maternal (CMD)
4009 8 3.3 Maternal CMD
3319 17 3.2 Maternal (CMD)
2931 20 3.1 ) ?
Normal (constitutive):
3103 45 4.2a ) DM
3954 48 3.5a ) ?
3953 62 3.4a ) DM
3252 40 3.1a Maternal DM
4148 38 3.0a ) ?
1778 53 2.8a ) DM
4267 19 2.6a Maternal DM
0076 31 2.4a ) ?
1578 33 2.3a ) DM
2416 26 1.8a ) DM
2146 36 1.8a Maternal DM
1264 36 1.6a Maternal DM
1265 30 1.5a Maternal DM
1958 42 1.5a ) DM
0055 26 1.5a ) ?
2621 33 1.4a DM
2608 20 1.3a Paternal DM
1497 61 0.7a ) DM
1413 58 0.6a ) DM
P70F Prenatal 0.6 Paternal ?
NOTE.—P57F and P70F are cell cultures established from tissues of DM fetuses (see Material
and Methods). All the other numbers refer to patients whose DNA was isolated from white
blood cells. CMD  congenital DM; (CMD)  onset probably congenital; and DM  disease
onset not congenital. Ellipses dots ()) indicate missing data. A question mark (?) indicates that
disease status is unknown.
a Smear of expansions.
lated (fig. 2a, 2b). A similar result was obtained on
BamHI  HpaII digests (not shown).
Hypermethylation of Disease Alleles in Severely
Affected Patients
We identified a number of DM patients whose DNAs
gave a very different pattern. When additionally cleaved
with methylation-sensitive enzymes SacII, HhaI, or
HpaII, the sizes of expanded fragments remained un-
changed (fig. 2b and 2c). There was one exceptional case
(P57F) showing partial methylation of the disease allele
on HpaII but complete methylation on HhaI digests.
Although there are many restriction sites (fig. 1), the
genomic SacII-HindIII fragment carrying the expanded
CTG repeat is resistant to the methylation-sensitive en-
zymes. The mutated genes of these particular patients,
therefore, in addition to the constitutive methylation de-
scribed above, show specific hypermethylation of a large
gene segment containing numerous CpG dinucleotides
(fig. 1). This hypermethylation of disease alleles was
found in both fibroblasts and leukocytes and was present
in an affected fetus (cell line P57F) as well as in adult
tissues.
Association of Hypermethylation with Large Repeat
Expansion and Severe Phenotype
In the DM patients who exhibited hypermethylation
of the disease allele (table 1), repeat expansions were
3.0–5.5 kb and appeared in most cases as sharp bands
on Southern blots. These patients were young and se-
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Figure 1 Schematic presentation of the DMPK gene structure and of the genomic region investigated (nt 1–1775). a, Exon-intron bound-
aries. b, CpG dinucleotide distribution. c, Sites of restriction enzymes in 5′ region of the CTG repeat. B  BamHI; H  HindIII; SI  SacI;
SII  SacII:   HhaI; and l  HpaII. In this scheme, the the first nucleotide corresponds to nt 12634 of the published sequence (Mahadevan
et al. 1993).
verely affected, most of them having congenital or very
early onset of the disease. One case of hypermethylation
was identified prenatally in a 16-wk-old fetus who was
the donor of the cell line P57F and was suspected to
develop congenital myotonic dystrophy because of a ma-
ternally inherited expansion. In contrast, the DM pa-
tients showing no specific methylation of the disease al-
lele were less severely affected, had older ages, and had
later onsets of disease. Their expansions were 0.6–4.2
kb, with those extending into the size range of the hy-
permethylated alleles appearing as broad smears. These
patterns suggest that the patients originally received
smaller expansions and that their smears of larger ex-
pansions resulted from continual instability of the repeat
in somatic tissues (Monckton et al. 1995; Wo¨hrle et al.
1995).
In Vivo Footprinting Studies
In the fetal cell line (P57F) and in fibroblasts from
normal adult individuals, the in vivo protein–DNA in-
teraction was studied in a segment of 120 bp (nt
1490–1610, according to the numbering system of fig.
1), located within the hypermethylated region of the mu-
tated gene (fig. 3). In normal cells (fig. 3, lane 2), we
identified a footprint at an Sp1 consensus binding site
(5′-GGC GGG-3′). In the P57F cells, carrying a normal
gene and a hypermethylated disease allele, the G residues
of this binding site were clearly visible, indicating miss-
ing of protein binding on either one or both alleles (fig.
3, lane 1).
Discussion
Our findings address the long-standing question why
the CTG-repeat expansion in the 3′ untranslated se-
quence of the DMPK gene can result in an autosomal
dominant and variable phenotype (Wieringa 1994). Sev-
eral hypotheses have been put forward. The precise level
of DMPK may be critical to normal cellular function,
and repeat expansion may give rise to haploinsufficiency
(Fu et al. 1993). The mutant allele may alter chromatin
structure and affect transcriptional activity of both the
DMPK and other closely linked genes on chromosome
19 (Boucher et al. 1995; Jansen et al. 1995; Otten and
Tapscott 1995; Wang and Griffith 1995). This conclu-
sion implies the existence of a locus control region (Wier-
inga 1994). The expansion of the repeat may be a dom-
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Figure 2 Southern blot analysis of DNAs from a normal indi-
vidual (a, lanes 1–3) from DM patients with early- or late-adult onset
(a, lanes 4–9; b, lanes 1–3), and from DM patients with congenital
onset (b, lanes 4–6; c, lanes 1–6). The DNAs were digested with SacI
 HindIII (a, lanes 1, 4, and 7; b, lane 4; c, lanes 1 and 4), with SacI
 HindIII  SacII (a, lanes 2, 5, and 8), or with SacI  HindIII 
HhaI (a, lanes 3, 6, and 9; b, lane 6; c, lanes 3 and 6) and were
hybridized to probe pM10M6. The patients’ identifiers (see table 1)
are as follows: 3953 (a, 4–6), 3954 (a, 7–9), 4148 (b, 1–3), 4211 (b,
4–6), P57F (c, 1–3), and 1496 (c, 4–6). With the exception of P57F,
all the DNA samples were isolated from white blood cells. P57F is a
cell line from a fetus suspected to have congenital DM.
Figure 3 In vivo footprint analysis showing the Sp1 consensus
binding site at position 13149–13156 in the published genomic se-
quence (Mahadevan et al. 1993). Lane 1, Fibroblasts of a DM fetus
(P57F) with hypermethylated disease allele. Lane 2, Fibroblasts of a
normal control individual. G  visible G residue; (G)  protected G
residue.
inant gain-of-function mutation exerted at the RNA
level (Wang et al. 1995; Timchenko et al. 1996). Repeat
expansion may lead to reduction of poly(A) mRNAs
(Carango et al. 1993; Fu et al. 1993; Hofmann-Radvanyi
et al. 1993; Pizzuti et al. 1993; Wang et al. 1995) af-
fecting DMPK gene expression at the posttranscriptional
level (Krahe et al. 1995). Transcripts from the mutant
allele have been found, by DMPK mRNA–specific in situ
hybridization analysis, to accumulate within intranu-
clear foci (Taneja et al. 1995). Subcellular fractionation
of RNA and the separated analysis of DMPK transcripts
from each allele revealed that trancripts from expanded
alleles were completely retained within the nucleus (Da-
vis et al. 1997; Hamshere et al. 1997). Nuclear retention
of DMPK transcripts occurs above a critical threshold
of 80–400 CTGs but does not effect the cytoplasmic
levels of transcripts from other genes at the DM locus
(Hamshere et al. 1997). Because there is no simple causal
relation between repeat size and phenotype, which is
documented by several examples of patients with similar
repeat sizes but different forms of the disease, many of
the proposed factors, as well as other mechanisms hith-
erto unknown, may contribute to the pathophysiology
of DM.
We have detected disease allele–specific DNA meth-
ylation in a segment proximal to the largely expanded
CTG repeat of severely affected patients, most if not all
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of them having congenital DM. This finding was sub-
stantiated by in vivo footprinting analysis detecting
binding of transcription factor Sp1. The Sp1 footprints
are present on unmethylated alleles, but most of them
are probably absent from the methylated gene sequence.
Sp1 binding is known to be methylation insensitive (Har-
rington et al. 1988) but to be involved in the regulation
of methylation at CpG islands (Brandeis et al. 1994).
Our results seem to be in contrast to a previous study
of DNA methylation in DM by Shaw et al. (1993). On
the 4.5-kb EcoRV-EcoRI fragment encompassing the
1.8-kb SacI-HindIII fragment that we investigated, they
did not find any methylation at the MspI-HpaII sites in
any DM patient. Ten patients with symptoms present at
birth, including hypotonia and respiratory problems,
were analyzed; however, the report of Shaw et al. did
not include information on either the ages of patients at
the time the blood samples were drawn or the sizes of
expansions and the patterns the expansions formed on
Southern analysis. The latter were shown from only one
congenital case, who presented an expansion of ∼3.5 kb,
forming a heterogeneous smear as broad as 1 kb. In our
study, we never detected any disease-specific methylation
with a smear. All the methylated alleles we described
formed sharp bands of expansions 13 kb in size that are
much more typical of young patients with congenital
DM.
Another difference between the two methylation stud-
ies is that Shaw et al. investigated only the MspI-HpaII
sites, whereas we studied the sites of different enzymes
(SacII, HhaI). HpaII sites were also studied in two cases,
both showing complete methylation of SacII and HhaI
sites on the disease alleles. One was a blood DNA sample
from a congenitally affected patient (1496) who also
showed complete methylation of the HpaII sites on the
BamHI fragment that includes probe M10M6. The other
DNA sample was from cultured cells of a DM fetus
(P57F) and showed only partial methylation of at least
one of the HpaII sites on the BamHI fragment. When
our findings and the results reported by Shaw et al. are
taken together, the following suggestion can be made:
hypermethylation of disease alleles may show variable
spreading toward the CTG repeat from a hypothetical
methylation center that could be located near the prox-
imal, constitutively methylated SacII site (fig. 1). There-
fore, the most distant HpaII sites at the 5′ end of the
CTG repeat could only occasionally be involved in (pos-
sibly unstable) methylation, in contrast to the distal SacII
site and the sites of HhaI, which are closer to the hy-
pothetical center and more distant from the CTG repeat.
Variable spreading and a possible age-dependent insta-
bility of methylation at the edge of the methylated region
might explain why Shaw et al. never detected an ex-
panded EcoRV-EcoRI fragment that was resistant to
cleavage with HpaII but we always found the expanded
SacI-HindIII fragment of congenitally affected patients
unchanged on SacII and HhaI digests.
In all patients who were found to have a hypermeth-
ylated disease allele, the expanded SacI-HindIII frag-
ments formed a sharp band on Southern analysis and
the expansion sizes were 13 kb. Only the latter condition
was met by some older patients showing smears of ex-
pansions and only the constititive methylation on both
alleles. In contrast to the younger patients, whose ex-
pansion sizes may still be similar to that of the originally
inherited progenitor allele, the smears in the older pa-
tients probably resulted from an ongoing mitotic insta-
bility of the repeat (Wo¨hrle et al. 1995), leading to slow
but continual further expansion throughout the patients’
lives, associated with an increase of size heterogeneity
(Monckton et al. 1995; Wong et al. 1995; Zatz et al.
1995). The overlap of repeat size in the two groups of
DM patients separated in table 1 is probably explained
by age-related unstable expansion, since hypermethy-
lation of expanded disease alleles may only occur in an
early developmental stage.
Because hypermethylation is associated with a large
size of the CTG repeat, an important question addresses
the origin of such a methylation. Hypermethylation of
adjacent CpG islands has also been found to occur with
large expansions of CGG and CCG repeats (Oberle´ et
al. 1991; Knight et al. 1993; Nancarrow et al. 1994;
Parrish et al. 1994; Jones et al. 1995; Schwemmle et al.
1997) and may be a consequence of expansion of these
repeats (Smith et al. 1994; Malter et al. 1997). A detailed
discussion of this interesting point is included in another
article (S. Schwemmle, unpublished data). In brief,
largely expanded triplet repeats form secondary struc-
tures interfering with chromatin structure and, in par-
ticular, with protein-DNA contacts by which CpG-island
methylation is regulated. For example, large expansion
of the CTG repeat probably eliminates an adjacent nu-
clease-hypersensitive site of a putative transcriptional en-
hancer of the DM locus-associated homeodomain pro-
tein (DMAHP) gene (Otten and Tapscott 1995; Klesert
et al. 1997). The 5′ end of the DMAHP gene, previously
identified by Boucher et al. (1995), is only ∼1 kb down-
stream of the CTG repeat of DMPK. Repeat expansion
converting the region surrounding the repeat to a more
condensed chromatin structure may lead to a reduced
accessibility of transcription factors and thereby to re-
duced expression in cis of DMAHP, as was recently
found to be the case in DM patients with expansions of
x900 triplets (Klesert et al. 1997; Thornton et al. 1997).
Such a conclusion must, however, remain speculative,
because there are other published data that demonstrate
no effect of CTG-repeat expansion on the level of ex-
pression of the 59 and DMAHP genes (Hamshere et al.
1997).
Instead of this significant, as yet unresolved discrep-
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ancy between the published data on DMAHP expres-
sion, there are two lines of evidence that the hyperme-
thylation of disease alleles, described in our study, may
have a functional significance in modifying the pheno-
typic manifestation of the DM mutation by affecting
local gene expression. (1) Hypermethylation is not only
associated with repeat expansion to x1,000 CTG trip-
lets but also with earlier onset and more severe mani-
festation of the disease. (2) The hypermethylated 3′ re-
gion of the DMPK gene is part of a large CpG island
with many CpGs being unmethylated in normal indi-
viduals and does, according to our footprinting results,
contain at least one site of protein-DNA interaction, in-
dicating its possible functional involvement in transcrip-
tional regulation.
Repeat expansion probably also affects transcription
factor binding to the putative enhancer of the down-
stream gene of DMAHP (Klesert et al. 1997). Therefore,
the large CpG island extending on both sides of the CTG
repeat could be a region controlling the chromatin struc-
ture and thereby the expression of genes at the DM-
chromosome locus.
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